Todd Harris, President and CEO at Tyra Biosciences, Inc. (TYRA), sold 29,087 shares at $24.19 ($704K) on 2024-09-20, disclosed to the SEC on 2024-09-20.
Scheduled sale ($704k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 3,500 | $84K | 11.9% |
| 2 | $24.30 | 5,671 | $138K | 19.6% |
| 3 | $24.30 | 5,671 | $138K | 19.6% |
| 4 | $25.10 | 27 | $678 | 0.1% |
| 5 | $24.19 | 7,109 | $172K | 24.4% |
| 6 | $24.19 | 7,109 |
| $172K |
| 24.4% |
| Total | $24.21 avg | 29,087 | $704K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-02-06 | $3.3M | — | Filing → |